Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniele Stéfanie Sara Lopes Lera-Nonose, Larissa Ferreira De Oliveira, Aline Brustolin, Thais Silva Santos, Jully Oyama, Áquila Carolina Fernandes Herculano Ramos-Milaré, Mariana De Souza Terron-Monich, Izabel Galhardo Demarchi, Quirino Alves De Lima Neto, Jorge Juarez Vieira Teixeira & Maria Valdrinez Campana Lonardoni. (2021) Genetic variations in the human immune system influence susceptibility to tegumentary leishmaniasis: a systematic review and meta-analysis. Expert Review of Clinical Immunology 17:5, pages 513-537.
Read now
Read now
Catarina de Souza, Janicy A. Carvalho, Alexandro S. Abreu, Lucas P. de Paiva, Jéssica A. R. Ambrósio, Milton Beltrame Junior, Marco A. de Oliveira, Josane Mittmann & Andreza R. Simioni. (2021) Polyelectrolytic gelatin nanoparticles as a drug delivery system for the promastigote form of Leishmania amazonensis treatment. Journal of Biomaterials Science, Polymer Edition 32:1, pages 1-21.
Read now
Read now
Articles from other publishers (14)
Ignace C. Roseboom, Hilde Rosing, Jos H. Beijnen & Thomas P. C. Dorlo. (2022) Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs. Biomedical Chromatography 37:7.
Crossref
Crossref
Nasrin Amiri Dashatan, Marzieh Ashrafmansouri, Mehdi Koushki & Nayebali Ahmadi. (2023) Effect of Resveratrol and Its Derivatives on Leishmania Viability: A Meta-Analysis. Journal of Advances in Medical and Biomedical Research 31:144, pages 1-13.
Crossref
Crossref
Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Mayron Antonio Candia Puma, Camila Simões de Freitas, Grasiele de Sousa Vieria Tavares, Daniela Pagliara Lage, Eduardo Antonio Ferraz Coelho & Miguel Angel Chávez-Fumagalli. (2023) Computer-aided drug design approaches applied to screen natural product’s structural analogs targeting arginase in Leishmania spp. F1000Research 12, pages 93.
Crossref
Crossref
Emma Leary, Ethan T. Anderson, Jasmine K. Keyes, Tristan R. Huskie, David J. Blake & Kenneth A. Miller. (2023) Improved synthesis of deoxyalpinoid B and quantification of antileishmanial activity of deoxyalpinoid B and sulforaphane. Bioorganic & Medicinal Chemistry 78, pages 117136.
Crossref
Crossref
Hector Alejandro Serrano Coll, Lucero Aristizábal-Parra, Eric Wan, Yohan Danilo López & Angela María Tobón. (2022) American Tegumentary Leishmaniasis: case series describing an enigmatic and neglected disease. CES Medicina 36:3, pages 106-114.
Crossref
Crossref
Adam Roberts, Rupa Nagar, Cordelia Brandt, Katherine Harcourt, Simon Clare, Michael A. J. Ferguson & Gavin J. Wright. (2022) The Leishmania donovani Ortholog of the Glycosylphosphatidylinositol Anchor Biosynthesis Cofactor PBN1 Is Essential for Host Infection. mBio 13:3.
Crossref
Crossref
Johnny Bullón, Laura Márquez, José Alejandro Fernández, César Scorzza, José Vicente Scorza, Jimmy Rodríguez, Atilio Cordero, Francia Véjar, Sonia Koteich-Khatib & Ana Forgiarini. (2021) A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient. Cosmetics 8:4, pages 115.
Crossref
Crossref
Julián Medina, Lissa Cruz-Saavedra, Luz Helena Patiño, Marina Muñoz & Juan David Ramírez. (2021) Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony. Parasites & Vectors 14:1.
Crossref
Crossref
Felipe de Paula Nogueira Cruz, Ailton Ferreira de Paula, Camila Tita Nogueira, Paulo Henrique Marques de Andrade, Leonardo Maurici Borges, Paulo Teixeira Lacava, Ilana L B C Camargo, Fernanda de Freitas Aníbal & Cristina Paiva de Sousa. (2021) Discovery of a Novel Lineage Burkholderia cepacia ST 1870 Endophytically Isolated from Medicinal Polygala paniculata Which Shows Potent In Vitro Antileishmanial and Antimicrobial Effects. International Journal of Microbiology 2021, pages 1-17.
Crossref
Crossref
John G. M. Mina, Rebecca L. Charlton, Edubiel Alpizar-Sosa, Douglas O. Escrivani, Christopher Brown, Amjed Alqaisi, Maria Paula G. Borsodi, Claudia P. Figueiredo, Emanuelle V. de Lima, Emily A. Dickie, Wenbin Wei, Robson Coutinho-Silva, Andy Merritt, Terry K. Smith, Michael P. Barrett, Bartira Rossi-Bergmann, Paul W. Denny & Patrick G. Steel. (2020)
Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the
Leishmania
Inositol Phosphorylceramide Synthase
. ACS Infectious Diseases 7:1, pages 47-63.
Crossref
Crossref
Ardic N, Ardic AF & Gunel Z. (2018) Leishmaniasis during the increased Syrian refugee traffic. Global Journal of Infectious Diseases and Clinical Research, pages 013-019.
Crossref
Crossref
Miguel Angel Chávez-Fumagalli, Mônica Santos Schneider, Daniela Pagliara Lage, Grasiele de Sousa Vieira Tavares, Débora Vasconcelos Costa Mendonça, Thaís Teodoro de Oliveira Santos, Rodrigo Maia Pádua, Ricardo Andrez Machado-de-Ávila, João Paulo Viana Leite & Eduardo Antonio Ferraz Coelho. (2018)
A Computational Approach Using Bioinformatics to Screening Drug Targets for
Leishmania infantum
Species
. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-9.
Crossref
Crossref
Lis Marie Monteiro, Raimar Löbenberg, Paulo Cesar Cotrim, Gabriel Lima Barros de Araujo & Nádia Bou-Chacra. (2017) Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. BioMed Research International 2017, pages 1-11.
Crossref
Crossref
Paula S. Lage, Miguel A. Chávez-Fumagalli, Juliana T. Mesquita, Laís M. Mata, Simone O. A. Fernandes, Valbert N. Cardoso, Manuel Soto, Carlos A. P. Tavares, João P. V. Leite, Andre G. Tempone & Eduardo A. F. Coelho. (2015) Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum. Parasitology Research 114:12, pages 4625-4635.
Crossref
Crossref